FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (734 ms)

Resources - All Kinds, Realm EU, Authority Hl7, Version R4

595 resources

Type:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

Prev Rows 200 - 400 Next
PackageIdentityName/TitleStatusDate
hl7.eu.fhir.idea4rcStructureDefinition/mcode-radiotherapy-technique Radiotherapy Technique Extensiondraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-distant-metastases-category Observation: TNM Distant Metastases Categorydraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-primary-tumor-category Observation: TNM Primary Tumor Categorydraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/mcode-tnm-regional-nodes-category Observation: TNM Regional Nodes Categorydraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-alcoholuse-eu-i4rc Observation: Alcohol usedraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-cci-eu-i4rc Observation: Charlson Comorbidity Indexdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-comorbidity-eu-i4rc Observation: Comorbiditiesdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-dateLastContact-eu-i4rc Observation: date of the last contactdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-ecog-performance-status-eu-i4rc Observation: ECOG Performance Statusdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-extraNodalExtension-eu-i4rc Observation: Radiological Extra-nodal extension (rENE)draft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-karnofsky-performance-statuseu-i4rc Observation: Karnofsky Performance Statusdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-lastFollowupStatus-eu-i4rc Observation: Status at the Last Follow Updraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-occurrencOtherCancer-eu-i4rc Observation: Occurrence of the other cancerdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-testResult-eu-i4rc Observation: test resultsdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-tobaccouse-eu-i4rc Observation: Tobacco usedraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-treatment-eu-i4rc Observation: Cancer Treatmentdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/observation-yesNo-eu-i4rc Observation: Yes / No assertionsdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/patient-eu-i4rc Patient: IDEA4RCdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/procedure-performedTiming Performed Timingdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/radiotherapy-energy-or-isotope Radiotherapy Energy or Isotopedraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/same-custodian-flag Same custodian flagdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-cancer-stage-group Observation: Sarcoma Cancer Stage Groupdraft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-extent-category Observation: Localized Category (Stage, Sarcoma)draft2024-07
hl7.eu.fhir.idea4rcStructureDefinition/sarcoma-locoRegional-category Observation: LocoRegional Category (Stage, Sarcoma)draft2024-07
hl7.eu.fhir.idea4rcValueSet/Gender-i4rc Gender: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/alcoholUsageStatus-athena-eu-i4rc Alcohol Usage Status: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/alcoholUsageStatus-snomed-eu-i4rc Alcohol Usage Status: SNOMED CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/beam-quality-i4rc Beam Qualityactive2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-chondroOsseousTumours-athena-vs Cancer Chondro Osseous Tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-diagnosis-athena-vs Cancer diagnosis: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-estAndRelatedTumours-athena-vs Cancer Endometrial stromal and related Tumors: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-event-type-vs Cancer Event Type: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-histologyAdenocarcinoma-athena-vs Cancer Histology Adenocarcinoma: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-histologyNeuroendocrine-athena-vs Cancer Histology Neuroendocrine: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-histologyOdontogenicCarcinoma-athena-vs Cancer Histology Odontogenic Carcinoma: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-histologySNUC-athena-vs Cancer Histology SNUC: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-histologySquamous-athena-vs Cancer Histology Squamous: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-histologySubgroupAdipocyticTumours-athena-vs Cancer Histology Subgroup Adipocytic Tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-histologySubgroupFmtTumours-athena-vs Cancer Histology Subgroup Fmt Tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-miscellaniousMesenchimalTumors-athena-vs Cancer Miscellanious mesenchimal tumors: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-mixedEpithelialAndMesenchymalTumours-athena-vs Cancer Mixed epithelial and mesenchymal tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-pericyticPerivascularTumours-athena-vs Cancer Pericytic Perivascular Tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-peripheralNerveSheathTumours-athena-vs Cancer Peripheral Nerve Sheath Tumors: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-skeletalMuscleTumours-athena-vs Cancer Skeletal Muscle Tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-smoothMuscleTumours-athena-vs Cancer Smooth Muscle Tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-socalledFibrohistiocyticTumours-athena-vs Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-stageGrading-athena-vs Cancer Stage Grading: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-stageGroup-athena-vs Cancer Stage Group: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-stageGroupValue-athena-vs Cancer Stage Group Value: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-tumoursOfUncertainDifferentiation-athena-vs Cancer Tumors Of Uncertain Differentiation: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-undifSmallRCelSarcBonAndSofTis-athena-vs Cancer undif. small round cell sarcomas of bone and soft tissue: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/cancer-vascularTumours-athena-vs Cancer Vascular Tumours: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/chemo-units-eu-i4rc Chemotherapy cumulative dose unitsdraft2024-07
hl7.eu.fhir.idea4rcValueSet/comorbidities-athena-eu-i4rc Comorbidities: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/comorbidities-sct-eu-i4rc Comorbidities: SNOMEDactive2024-07
hl7.eu.fhir.idea4rcValueSet/country-eu-i4rc Country: athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/disease-extent-category-vs Sarcoma Staging: localized diseasedraft2024-07
hl7.eu.fhir.idea4rcValueSet/drugsAtc-eu-i4rc Antineoplastic and immunostimulating agentsdraft2024-07
hl7.eu.fhir.idea4rcValueSet/ecog-i4rc ECOG Performance Statusactive2024-07
hl7.eu.fhir.idea4rcValueSet/event-type-eu-i4rc Event Typeactive2024-07
hl7.eu.fhir.idea4rcValueSet/extranodal-extension-i4rc Extranodal Extensiondraft2024-07
hl7.eu.fhir.idea4rcValueSet/geneticTestPerformed-eu-i4rc Genetic Tests performed (Yes/no/Unk)active2024-07
hl7.eu.fhir.idea4rcValueSet/genito-urinary-subsite-athena-i4rc Genito urinary subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/hypopharynx-subsite-athena-i4rc Hypopharynx subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/hypopharynx-subsite-sct-i4rc Hypopharynx subsite: Snomed CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/intra-abdominal-subsite-athena-i4rc Intra abdominal subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/intra-thoracic-subsite-athena-i4rc Intra thoracic subsite : Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/larynx-subsite-athena-i4rc Larynx subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/larynx-subsite-sct-i4rc Larynx subsite: Snomed CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/lip-subsite-athena-i4rc Lip subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/lip-subsite-sct-i4rc Lip subsite: Snomed CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/locoregional-category-vs Sarcoma Staging: loco-regional categorydraft2024-07
hl7.eu.fhir.idea4rcValueSet/margins-after-surgery-eu-i4rc Margins After Surgeryactive2024-07
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-07
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-07
hl7.eu.fhir.idea4rcValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-07
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-07
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-07
hl7.eu.fhir.idea4rcValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-07
hl7.eu.fhir.idea4rcValueSet/metastasis-disorder-athena-vs Metastatis: Athenadraft2024-07
hl7.eu.fhir.idea4rcValueSet/nasal-paranasal-subsite-athena-i4rc Nasal cavity and paranasal sinuses subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/nasal-paranasal-subsite-sct-i4rc Nasal cavity and paranasal sinuses subsite: Snomed CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/nasal-subsite-athena-i4rc Subsites: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/nasal-subsite-sct-i4rc Subsites: SNOMED CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/nasopharynx-subsite-athena-i4rc Nasopharynx subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/nasopharynx-subsite-sct-i4rc Nasopharynx subsite: Snomed CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/obsYesNo-code-eu-i4rc Types of Yes/No observationsactive2024-07
hl7.eu.fhir.idea4rcValueSet/occurrence-other-cancer-i4rc Occurrence of other canceractive2024-07
hl7.eu.fhir.idea4rcValueSet/oralCavity-subsite-athena-i4rc Oral cavity subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/oralCavity-subsite-sct-i4rc Oral cavity subsite: Snomed CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/oropharynx-subsite-athena-i4rc Oropharynx subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/oropharynx-subsite-sct-i4rc Oropharynx subsite: Snomed CTactive2024-07
hl7.eu.fhir.idea4rcValueSet/pathologicalM-i4rc Pathological Mactive2024-07
hl7.eu.fhir.idea4rcValueSet/pathologicalN-i4rc Pathological Nactive2024-07
hl7.eu.fhir.idea4rcValueSet/pathologicalT-i4rc Pathological Tactive2024-07
hl7.eu.fhir.idea4rcValueSet/pos-neg-nt-athena-eu-i4rc Positive-Negative-No Test: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/race-i4rc Raceactive2024-07
hl7.eu.fhir.idea4rcValueSet/reason-for-end-of-treatment-eu-i4rc Reason For End Of Treatmentactive2024-07
hl7.eu.fhir.idea4rcValueSet/setting-radiotherapy-i4rc Setting Radiotherapyactive2024-07
hl7.eu.fhir.idea4rcValueSet/simpleResult-eu-i4rc Simple measuresactive2024-07
hl7.eu.fhir.idea4rcValueSet/site-of-metastasis-i4rc Site of metastasisactive2024-07
hl7.eu.fhir.idea4rcValueSet/site-qualifier-i4rc Body site qualifieractive2024-07
hl7.eu.fhir.idea4rcValueSet/siteRare-i4rc Site rare (IDEA4RC)active2024-07
hl7.eu.fhir.idea4rcValueSet/smokingStatus-athena-eu-i4rc Current Smoking Status: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/smokingStatus-loinc-eu-i4rc Smoking Status: LOINCactive2024-07
hl7.eu.fhir.idea4rcValueSet/status-last-followup-i4rc Status at the Last Follow Upactive2024-07
hl7.eu.fhir.idea4rcValueSet/surgery-complication-eu-i4rc Surgery Complicationactive2024-07
hl7.eu.fhir.idea4rcValueSet/surgery-intention-eu-i4rc Surgery Intentionactive2024-07
hl7.eu.fhir.idea4rcValueSet/surgery-outcome-eu-i4rc Surgery Outcomeactive2024-07
hl7.eu.fhir.idea4rcValueSet/surgical-complications-eu-i4rc Surgical Complicationsactive2024-07
hl7.eu.fhir.idea4rcValueSet/tobacco-product-eu-i4rc Tobacco Productactive2024-07
hl7.eu.fhir.idea4rcValueSet/treatment-completed-as-planned-i4rc Treatment completed as plannedactive2024-07
hl7.eu.fhir.idea4rcValueSet/treatment-response-eu-i4rc Treatment Responseactive2024-07
hl7.eu.fhir.idea4rcValueSet/treatment-setting-eu-i4rc Treatment Settingactive2024-07
hl7.eu.fhir.idea4rcValueSet/treatment-technique-i4rc Treatment Techniqueactive2024-07
hl7.eu.fhir.idea4rcValueSet/trunk-wall-subsite-athena-i4rc Trunk wall subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/type-of-biopsy-eu-i4rc Type of Biopsyactive2024-07
hl7.eu.fhir.idea4rcValueSet/type-of-diagnosis-eu-i4rc Type of Diagnosisactive2024-07
hl7.eu.fhir.idea4rcValueSet/type-of-surgical-approach-eu-i4rc Type of surgical approachactive2024-07
hl7.eu.fhir.idea4rcValueSet/type-of-systemic-treatment-eu-i4rc Type of Systemic Treatmentactive2024-07
hl7.eu.fhir.idea4rcValueSet/type-of-treatment-eu-i4rc Type of Treatmentactive2024-07
hl7.eu.fhir.idea4rcValueSet/upperLower-limbs-subsite-athena-i4rc Upper and Lower limbs subsite: Athenaactive2024-07
hl7.eu.fhir.idea4rcValueSet/vs-affectedOrgan-eu-i4rc Affected Organs (surgery)active2024-07
hl7.eu.fhir.idea4rcValueSet/vs-calcest-eu-i4rc Calculated|Estimateddraft2024-07
hl7.eu.fhir.idea4rcValueSet/vs-npunk-eu-i4rc Not Performed|Unknowndraft2024-07
hl7.eu.fhir.idea4rcValueSet/vs-radiotherapyDeviceType-eu-i4rc Radiotherapy Device Typedraft2024-07
hl7.eu.fhir.idea4rcValueSet/vs-surgicalProcedureCategory-eu-i4rc Surgical Procedure Categoryactive2024-07
hl7.eu.fhir.idea4rcValueSet/vs-surgicalProcedureType-eu-i4rc Surgical Procedure Typeactive2024-07
hl7.eu.fhir.idea4rcValueSet/yes-no-unk-athena-eu-i4rc Yes-No-Unk: Athenaactive2024-07
hl7.fhir.eu.laboratoryhttp://example.org/lab-codes Laboratory Code: exampledraft2024-09
hl7.fhir.eu.laboratoryConceptMap/ConceptMap-eu-diagRptStatus2CompStatus DiagnosticReport to Composition statusdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/author2FHIR-eu-lab eHN Author to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/labRpt2FHIR-eu-lab eHN Lab Report to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/legalAuth2FHIR-eu-lab eHN Recipient to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/order2FHIR-eu-lab eHN Order to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/payer2FHIR-eu-lab eHN Payer to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/recipient2FHIR-eu-lab eHN Recipient to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/result2FHIR-eu-lab eHN Result to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/specimen2FHIR-eu-lab eHN Specimen to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/subject2FHIR-eu-lab eHN Subject to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryConceptMap/validator2FHIR-eu-lab eHN Validator to this guide Mapdraft2024-09
hl7.fhir.eu.laboratoryImplementationGuide/hl7.fhir.eu.laboratory HL7 Europe Laboratory Reportdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Address-eu Address (EU)draft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Author A.1.5 - Authordraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/BodyStructure-eu-lab Body structure: Laboratorydraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Bundle-eu-lab Bundle: Laboratory Reportdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Composition-eu-lab Composition: Laboratory Reportdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/DiagnosticReport-eu-lab DiagnosticReport: Laboratory Reportdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/HumanName-eu HumanName (Eu)draft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/HumanName-obl-eu-lab Human Name: Obligationsdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/LabReport A - Laboratory Reportdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/LegalAuthenticator A.1.6 - Legal authenticatordraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Observation-obl-eu-lab Observation: Obligationsdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Observation-resultslab-eu-lab Observation Results: laboratorydraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Order A2, A3 - Orderdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Patient-animal-eu-lab Patient: Animaldraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Patient-eu-lab Patient: Persondraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Patient-obl-eu-lab Patient: Obligationsdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Payer A.1.3 - Health insurance and payment informationdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Practitioner-eu-lab Practitioner: Laboratory Reportdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/PractitionerRole-eu-lab PractitionerRole: Laboratory Reportdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Quantity-eu-lab Quantity (Eu Lab)draft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Ratio-eu-lab Ratio (Eu Lab)draft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Recipient A.1.4 - Information recipientdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Result A.5 - Results data elementsdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/ServiceRequest-eu-lab ServiceRequest: Laboratory Orderdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/ServiceRequest-obl-eu-lab ServiceRequest: Obligationsdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Specimen-eu-lab Specimen: Laboratorydraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Specimen-obl-eu-lab Specimen: Obligationsdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/SpecimenLab A.4 - Specimen informationdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Substance-additive-eu-lab Substance: Specimen Additive Substancedraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/Validator A.1.7 - Result validatordraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/composition-diagnosticReportReference Document DiagnosticReport Referencedraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/observation-certifiedRefMaterialCodeable Certified Reference Material: CodeableConceptdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/observation-certifiedRefMaterialIdentifer Certified Reference Material: Identifierdraft2024-09
hl7.fhir.eu.laboratoryStructureDefinition/observation-deviceLabTestKit Device Laboratory Test Kitdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-certifiedRefMaterial-eu-lab Laboratory Certified Reference Materialdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-laterality-eu-lab Body Structure Lateralitydraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-obsCode-eu-lab Laboratory Codedraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-obsCode-loinc-eu-lab Laboratory Code: LOINCdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-obsCode-npu-eu-lab Laboratory Code: NPUdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-orderCodes-eu-lab Laboratory Orderdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-reportType-eu-lab Laboratory Report Typesdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-siteQualifier-eu-lab Body Structure Qualifierdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-specialty-eu-lab Laboratory Specialtydraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-speciesType-eu-vs Types of speciesdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-specimenAdditive-eu-lab Specimen Additivedraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-specimenContainer-eu-lab Specimen Containerdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-specimenType-eu-lab Specimen Typesdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-studyType-eu-lab Laboratory Study Typesdraft2024-09
hl7.fhir.eu.laboratoryValueSet/lab-technique-eu-lab Laboratory Techniquesdraft2024-09
hl7.fhir.eu.mpdConceptMap/eD2FHIR-eu-mpd eHN Dispense to this guide Mapdraft2024-08
hl7.fhir.eu.mpdConceptMap/eP2FHIR-eu-mpd eHN Subject to this guide Mapdraft2024-08
hl7.fhir.eu.mpdConceptMap/medProd2FHIR-eu-mpd eHN Medicinal Product to this guide Mapdraft2024-08
hl7.fhir.eu.mpdImplementationGuide/hl7.fhir.eu.mpd HL7 Europe Medication Prescription and Dispensedraft2024-08
hl7.fhir.eu.mpdStructureDefinition/Dispensation B.1 Dispensation information (provided by the dispensing pharmacy)draft2024-08
hl7.fhir.eu.mpdStructureDefinition/Medication-eu-mpd Medication: MPDdraft2024-08
hl7.fhir.eu.mpdStructureDefinition/MedicationDispense-eu-mpd MedicationDispense: MPDdraft2024-08
hl7.fhir.eu.mpdStructureDefinition/MedicationRequest-eu-mpd MedicationRequest: MPDdraft2024-08
hl7.fhir.eu.mpdStructureDefinition/MedicinalProduct A1.4 Identification of the prescribed productdraft2024-08
hl7.fhir.eu.mpdStructureDefinition/Patient-eu-mpd Patient: MPDdraft2024-08
hl7.fhir.eu.mpdStructureDefinition/Prescription A - Prescriptiondraft2024-08
hl7.fhir.eu.mpdStructureDefinition/Subject A.1.1 Patient administrative datadraft2024-08
hl7.fhir.eu.mpdStructureDefinition/ihe-ext-medication-characteristic Medication - Characteristicdraft2024-08
hl7.fhir.eu.mpdStructureDefinition/ihe-ext-medication-classification Medication - Classificationdraft2024-08
hl7.fhir.eu.mpdStructureDefinition/ihe-ext-medication-device Medication - Devicedraft2024-08
hl7.fhir.eu.mpdStructureDefinition/ihe-ext-medication-productname Medication - Product Namedraft2024-08
hl7.fhir.eu.mpdStructureDefinition/ihe-ext-medication-sizeofitem Medication - Size of Itemdraft2024-08
hl7.fhir.eu.mpdStructureDefinition/ihe-ext-medication-strengthsubstance Medication - Strength substancedraft2024-08
hl7.fhir.eu.mpdStructureDefinition/ihe-ext-medication-strengthtype Medication - Strength typedraft2024-08
hl7.fhir.eu.mpdStructureDefinition/ihe-ext-medication-unitofpresentation Medication - Unit of presentationdraft2024-08
hl7.eu.fhir.xpandhImplementationGuide/hl7.eu.fhir.xpandh XpanDH Projectdraft2024-07
hl7.eu.fhir.xpandhStructureDefinition/Patient-eu-xpandh Patient: XpanDHdraft2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAbsentOrUnknownAllergy Absent or Unknown Allergiesactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAbsentOrUnknownDevice Absent or Unknown Deviceactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAbsentOrUnknownMedication Absent or Unknown Medicationactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAbsentOrUnknownProblem Absent or Unknown Problemactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAbsentOrUnknownProcedure Absent or Unknown Procedureactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAdverseEventType Adverse Event Typeactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAllergenNoDrug Allergen No Drugactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAllergyCertainty Allergy Certaintyactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIAllergyStatus Allergy Statusactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIBloodGroup Blood Groupactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIBloodPressure Blood Pressureactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSICertainty Certaintyactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSICodeProb Problemsactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIConfidentiality Confidentialityactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSICountry Countryactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSICriticality Criticalityactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSICurrentPregnancyStatus Current Pregnancy Statusactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIDocumentCode Document Codeactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIDoseForm Dose Formactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIHealthcareProfessionalRole Healthcare Professional Roleactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIHospitalDischargeReportType Hospital Discharge Report Typeactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIProcedure Procedureactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIReactionAllergy Reaction Allergyactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSISeverity Severityactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSISocialHistory eHDSI Social Historyactive2024-07
hl7.eu.fhir.xpandhValueSet/eHDSIVaccine Vaccineactive2024-07
hl7.eu.fhir.pcspCodeSystem/cs-generic-eu-pcsp PCSP Code Systemdraft2024-09
hl7.eu.fhir.pcspCodeSystem/cs-radiotherapy-pcsp Radiotherapy sitesactive2024-09
hl7.eu.fhir.pcspCodeSystem/cs-recommendation-eu-pcsp PCSP Recommendationsdraft2024-09
hl7.eu.fhir.pcspCodeSystem/cs-riskcondition-eu-pcsp PCSP Conditions at riskdraft2024-09
hl7.eu.fhir.pcspCodeSystem/cs-riskfactor-eu-pcsp Risk Factorsdraft2024-09
hl7.eu.fhir.pcspImplementationGuide/hl7.eu.fhir.pcsp PanCareSurPass Project HL7 FHIR Implementation Guidedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/BiologicallyDerivedProduct-sct-eu-pcsp BiologicallyDerivedProduct: Stem Celldraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Bundle-eu-pcsp Bundle: Survivor Passportdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/CarePlan-eu-pcsp CarePlan: PCSP-generated plandraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Chemotherapy Chemotherapydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Composition-surpass-eu-pcsp Composition: Survivor Passportdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Condition-gvhd-eu-pcsp Condition: GvHDdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Condition-otherinfos-eu-pcsp Condition: Othersdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Condition-primaryCancer-eu-pcsp Condition: Primary Cancerdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Condition-secondaryCancer-eu-pcsp Condition: Metastatic Cancerdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Condition-toxicity-eu-pcsp Condition: Severe Toxicitydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Diagnosis Diagnosisdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/DocMetadataFSE Metadata FSE Italydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/DocumentReference-eu-pcsp DocumentReference: PCSPdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Encounter-eu-pcsp Encounter: Treatment Centerdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/FrontLineTreatment Front Line Treatmentdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Location-eu-pcsp Location: PCSPdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/MajorSurgery Major Surgerydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/MedicationAdministration-eu-pcsp MedicationAdministration: Chemotherapydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/MedicationStatement-eu-pcsp MedicationStatement: Chemotherapydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Observation-bld-abo-rh-eu-pcsp Observation: Blood type/RHdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Observation-cumulativeDoseChemo-eu-pcsp Observation: Chemotherapy Cumulative Dosedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Observation-diagnosis-eu-pcsp Observation: Diagnosis detailsdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Observation-predisposition-eu-pcsp Observation: Hereditary Predispositiondraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Observation-riskfactor-eu-pcsp Observation: Risk Factordraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Observation-totalDoseRad-eu-pcsp Observation: Radiotherapy Total Dose PCSPdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Organization-center-eu-pcsp Organization: Primary Treatment Center / Center of diagnosisdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/OtherInfos Other info and relevant eventsdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Patient-eu-pcsp Patient: PCSPdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/PlanDefinition-flt-eu-pcsp PlanDefinition: Front Line Treatmentdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/PlanOfCare Care Plandraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-cryopreservation-otherinfos-eu-pcsp Procedure: Cryopreservationdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-cvc-otherinfos-eu-pcsp Procedure: Catheterdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-flt-eu-pcsp Procedure: Front Line Treatmentdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-radiotheraphy-eu-pcsp Procedure: Radiotherapydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-radiotheraphyBoost-eu-pcsp Procedure: Radiotherapy Boostdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-radiotheraphyShield-eu-pcsp Procedure: Radiotherapy Shieldingdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-sct-eu-pcsp Procedure: Stem Cell Transplantationdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-sct-prophylaxis-eu-pcsp Procedure: SCT Prophylaxisdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-surgery-eu-pcsp Procedure: Surgerydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-transfusion-otherinfos-eu-pcsp Procedure: Transfusion other infosdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Procedure-treatment-otherinfos-eu-pcsp Procedure: Other Treatmentsdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Radiotherapy Radiotherapydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/RelapseAfterFLT Progression-Relapse after FLTdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/RelapseDuringFLT Progression-Relapse during FLTdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/StemCellTransplantation Stem Cell Transplantationdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/Subject Subject of caredraft2024-09
hl7.eu.fhir.pcspStructureDefinition/SurPass SurPass V2.0draft2024-09
hl7.eu.fhir.pcspStructureDefinition/TreatmentSummary Treatment Summarydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/annotation-type Annotation Typedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/condition-previousStatus Previous Statusdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/condition-relapseType Relapse Typedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/event-location Act Locationdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/mcode-body-location-qualifier Body Location Qualifierdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/mcode-cancer-stage-group Observation: Cancer Stage Groupdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/mcode-condition-related Condition related to resourcedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/mcode-laterality-qualifier Laterality Qualifierdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/mcode-tnm-distant-metastases-category Observation: TNM Distant Metastases Categorydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/mcode-tnm-primary-tumor-category Observation: TNM Primary Tumor Categorydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/mcode-tnm-regional-nodes-category Observation: TNM Regional Nodes Categorydraft2024-09
hl7.eu.fhir.pcspStructureDefinition/procedure-fltArm Randomization arm for trialdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/procedure-notAffectedOrgan Not affected Organdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/procedure-performedTiming Performed Timingdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/procedure-usedReference Procedure Used Referencedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/radiotherapy-energy-or-isotope Radiotherapy Energy or Isotopedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/resource-relatedInfo Resource related informationdraft2024-09
hl7.eu.fhir.pcspStructureDefinition/sct-donor-type Stem Cell Donor Typedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/sct-source-type Stem Cell Source Typedraft2024-09
hl7.eu.fhir.pcspStructureDefinition/surgery-sacrifiedOrgan Sacrified organdraft2024-09
hl7.eu.fhir.pcspValueSet/ChemoUnitsVs Chemotherapy cumulative dose unitsdraft2024-09
hl7.eu.fhir.pcspValueSet/activeResolved-condition-vs Active or resolved Conditiondraft2024-09
hl7.eu.fhir.pcspValueSet/annotation-type-vs Annotation typedraft2024-09
hl7.eu.fhir.pcspValueSet/cond-test-vs Conditions: follow updraft2024-09
hl7.eu.fhir.pcspValueSet/drugsAtc-eu-pcsp Antineoplastic and immunostimulating agentsdraft2024-09
hl7.eu.fhir.pcspValueSet/grade-test-vs Grade: follow updraft2024-09
hl7.eu.fhir.pcspValueSet/laterality-qualifier-lrub-vs Laterality Qualifier Value Setdraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-body-location-qualifier-vs Body Location Qualifier Value Setdraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-cancer-stage-group-vs Stage Group Value Setdraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-cancer-staging-system-vs Cancer Staging System Value Setdraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-observation-codes-stage-group-vs Observation Codes for Stage Group Categorydraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-09
hl7.eu.fhir.pcspValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-09
hl7.eu.fhir.pcspValueSet/morphologicAbnormality-eu-vs Morphologically abnormal structuredraft2024-09
hl7.eu.fhir.pcspValueSet/otherInfos-condition-vs Other Infors Conditiondraft2024-09
hl7.eu.fhir.pcspValueSet/relapse-type-vs Relapse type (Local/Distant/Combined)draft2024-09
hl7.eu.fhir.pcspValueSet/toxicityseverity-vs Toxicity Severitydraft2024-09
hl7.eu.fhir.pcspValueSet/vs-Gvhd-acute-grade-eu-pcsp Acute Gvhd Gradedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-Gvhd-chronic-grade-eu-pcsp Chronic Gvhd conditiondraft2024-09
hl7.eu.fhir.pcspValueSet/vs-Gvhd-type-eu-pcsp Gvhd conditiondraft2024-09
hl7.eu.fhir.pcspValueSet/vs-ProsthesisType-eu-pcsp Prosthesis Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-ProstheticProcedureType-eu-pcsp Prosthetic Surgical Procedure Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-action-eu-pcsp Surgical Actionsdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-affectedOrgan-eu-pcsp Affected Organs (surgery)draft2024-09
hl7.eu.fhir.pcspValueSet/vs-amputationProcedureType-eu-pcsp Amputation Surgical Procedure Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-brachytherapyType-eu-pcsp Brachytherapy Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-calcest-eu-pcsp Calculated|Estimateddraft2024-09
hl7.eu.fhir.pcspValueSet/vs-colostomyProcedureType-eu-pcsp Colostomy Surgical Procedure Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-docref-doctype-eu-pcsp Document Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-flt-plan-type-eu-pcsp FLT Plan Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-fromToPosteriorAnterior-eu-pcsp Body Location Qualifier Value Setdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-gastrostomyProcedureType-eu-pcsp Gastrostomy Surgical Procedure Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-hereditary-eu-pcsp Hereditary Predispositions or Diseasedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-iccc3-eu-pcsp ICCC-3draft2024-09
hl7.eu.fhir.pcspValueSet/vs-icd10-predisposition-eu-pcsp Hereditary Predispositions (ICD10)draft2024-09
hl7.eu.fhir.pcspValueSet/vs-icdo3-morphology-eu-pcsp ICD-O-3 Morphologydraft2024-09
hl7.eu.fhir.pcspValueSet/vs-icdo3-topography-eu-pcsp ICD-O-3 Topographydraft2024-09
hl7.eu.fhir.pcspValueSet/vs-isotopes-eu-pcsp Radiotherapy Isotopesdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-naunk-eu-pcsp Not Applicable|Unknowndraft2024-09
hl7.eu.fhir.pcspValueSet/vs-npunk-eu-pcsp Not Performed|Unknowndraft2024-09
hl7.eu.fhir.pcspValueSet/vs-orpha-predisposition-eu-pcsp Hereditary Predispositions (Orphacode)draft2024-09
hl7.eu.fhir.pcspValueSet/vs-othUnkTxt-eu-pcsp Other/Unknown/Textdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-radiotherapy-pcsp Radiotherapy sitesdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-radiotherapyDeviceType-eu-pcsp Radiotherapy Device Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-radiotherapyDoseType-eu-pcsp Radiotherapy Dose Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-radiotherapyDoseUnit-eu-pcsp Radiotherapy dose unitsdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-radiotherapyType-eu-pcsp Radiotherapy Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-recommendation-eu-pcsp Recommendationsdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-riskcondition-eu-pcsp Conditions at riskdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-riskfactor-eu-pcsp Risk Factorsdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-roa-eu-pcsp Route of administrationdraft2024-09
hl7.eu.fhir.pcspValueSet/vs-sacrifiedOrgan-eu-pcsp Sacrified Organs (surgery)draft2024-09
hl7.eu.fhir.pcspValueSet/vs-sct-donorType-eu-pcsp Stem Cell Donor typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-sct-prophylaxis-cathegory-eu-pcsp SCT Prophylaxis Cathegorydraft2024-09
hl7.eu.fhir.pcspValueSet/vs-sct-prophylaxis-type-eu-pcsp SCT Prophylaxis Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-sct-sourceType-eu-pcsp Stem Cell Source typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-sct-timing-eu-pcsp Before/after proceduredraft2024-09
hl7.eu.fhir.pcspValueSet/vs-sct-type-eu-pcsp Stem Cell Transplantation typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-shuntProcedureType-eu-pcsp Shunt Procedure Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-surgicalProcedureType-eu-pcsp Surgical Procedure Typedraft2024-09
hl7.eu.fhir.pcspValueSet/vs-unknownOther-eu-pcsp Unknown|Otherdraft2024-09
hl7.eu.fhir.gh-ipsImplementationGuide/hl7.eu.fhir.gh-ips Gravitate Health FHIR Implementation Guide (FHIR R4)active2024-09
hl7.eu.fhir.xpandh.labCodeSystem/lab-localCs-xpandh Laboratory local codes Code Systemactive2024-09
hl7.eu.fhir.xpandh.labConceptMap/ConceptMap-eu-diagRptStatus2CompStatus DiagnosticReport to Composition statusdraft2024-09
hl7.eu.fhir.xpandh.labImplementationGuide/hl7.eu.fhir.xpandh.lab XpanDH Laboratory Reportdraft2024-09
hl7.eu.fhir.xpandh.labStructureDefinition/Bundle-lab-xpandh Bundle: Laboratory Reportdraft2024-09
hl7.eu.fhir.xpandh.labStructureDefinition/Composition-lab-xpandh Composition: Laboratory Reportdraft2024-09
hl7.eu.fhir.xpandh.labStructureDefinition/DiagnosticReport-lab-xpandh DiagnosticReport: Laboratory Reportdraft2024-09
hl7.eu.fhir.xpandh.labStructureDefinition/Observation-results-lab-xpandh Observation Results: laboratorydraft2024-09
hl7.eu.fhir.xpandh.labStructureDefinition/Patient-eu-xpandh Patientdraft2024-09
hl7.eu.fhir.xpandh.labStructureDefinition/Practitioner-eu-xpandh Practitionerdraft2024-09
hl7.eu.fhir.xpandh.labStructureDefinition/PractitionerRole-eu-xpandh PractitionerRoledraft2024-09
hl7.eu.fhir.xpandh.labStructureDefinition/ServiceRequest-lab-xpandh ServiceRequest: Laboratory Orderdraft2024-09
hl7.eu.fhir.xpandh.labValueSet/lab-localVs-xpandh Local Laboratory Codes VSdraft2024-09
hl7.fhir.eu.extensionsImplementationGuide/hl7.fhir.eu.extensions HL7 Europe Extensionsactive2024-02
hl7.fhir.eu.extensionshttp://hl7.eu/fhir/StructureDefinition/composition-basedOn-order-or-requisition Document Based On Orderactive2024-02
hl7.fhir.eu.extensionshttp://hl7.eu/fhir/StructureDefinition/information-recipient Information recipientactive2024-02

XIG built as of 16 Sep 2024. Found 39646 resources in 661 packages.